Anellotech to plan commercial plant for Bio-TCat unit

0
569

In New York, Anellotech confirms significant progress in its Bio-TCat technology development program and has begun planning for scale-up design and engineering of a commercial plant with its process development and design partner IFPEN and commercialization, engineering, and licensing partner Axens.

Anellotech is pioneering an innovative manufacturing process to produce cost-competitive renewable chemicals and fuels from non-food biomass. Its patented Bio-TCat thermal-catalytic technology produces a mixture of benzene, toluene and xylene (BTX) which can be used to make important polymers such as polyester, polycarbonate, and nylon, or high-octane gasoline blendstock. Jacobs, a globally respected engineering firm, recently confirmed that the Bio-TCat process enables a CO2 emission reduction potential of 70-90% when compared to petroleum-derived equivalents. Co-product gas streams from Bio-TCat can be used to make significant amounts of renewable electricity, hydrogen or cellulosic ethanol using third party technologies.

David Sudolsky, President & CEO of Anellotech, said, “Our TCat-8 unit consistently demonstrates stable, economic performance as we continue to further optimize process conditions. These advancements come from the dedicated and coordinated efforts of Anellotech, IFPEN and Johnson Matthey engineers and scientists. We are excited to begin commercial plant engineering activities with our partner Axens and open up engagement with potential partners for investments and locations for the first commercial plant.”